Follow
Jiangeng Huang
Title
Cited by
Cited by
Year
Replication or exploration? Sequential design for stochastic simulation experiments
M Binois, J Huang, RB Gramacy, M Ludkovski
Technometrics 61 (1), 7-23, 2019
1242019
Analyzing stochastic computer models: A review with opportunities
E Baker, P Barbillon, A Fadikar, RB Gramacy, R Herbei, D Higdon, ...
Statistical Science 37 (1), 64-89, 2022
50*2022
On‐site surrogates for large‐scale calibration
J Huang, RB Gramacy, M Binois, M Libraschi
Applied Stochastic Models in Business and Industry 36 (2), 283-304, 2020
132020
Mosunetuzumab monotherapy continues to demonstrate durable responses in patients with relapsed and/or refractory follicular lymphoma after≥ 2 prior therapies: 3-year follow-up …
SJ Schuster, LH Sehn, NL Bartlett, M Matasar, S Assouline, P Giri, ...
Blood 142, 603, 2023
82023
Multi-output calibration of a honeycomb seal via on-site surrogates
J Huang, RB Gramacy
Technometrics 64 (4), 548-563, 2022
42022
CAMMA 1: a multicenter phase Ib trial evaluating the safety, pharmacokinetics, and activity of cevostamab-containing regimens in patients with relapsed or refractory multiple …
R Vij, H Schade, S Trudel, AC Chang, J Huang, D Samineni, T Sumiyoshi, ...
J. Clin. Oncol 40, 16, 2022
32022
Mosunetuzumab Monotherapy Demonstrates Activity and a Manageable Safety Profile in Patients with Relapsed or Refractory Richter's Transformation
CY Cheah, S Assouline, R Baker, NL Bartlett, D El-Sharkawi, P Giri, M Ku, ...
Blood 142, 614, 2023
22023
A frequentist approach to dynamic borrowing
R Li, R Lin, J Huang, L Tian, J Zhu
Biometrical Journal 65 (7), 2100406, 2023
12023
CAMMA 3: A multicenter phase Ib trial evaluating the safety, pharmacokinetics, and activity of subcutaneous cevostamab monotherapy in patients with relapsed or refractory …
S Delimpasi, H Quach, M Cavo, PJ Ho, C Lee, A Santoro, R Schots, ...
J. Clin. Oncol 40, 16, 2022
12022
Sequential learning, large-scale calibration, and uncertainty quantification
J Huang
Virginia Tech, 2019
12019
PB2034: CAMMA 1: A MULTICENTER PHASE IB TRIAL EVALUATING THE SAFETY, PHARMACOKINETICS AND ACTIVITY OF CEVOSTAMAB-CONTAINING REGIMENS IN PATIENTS WITH RELAPSED OR REFRACTORY …
R Vij, H Schade, S Trudel, AC Chang, J Huang, D Samineni, T Sumiyoshi, ...
HemaSphere 6, 1905-1906, 2022
2022
Bayesian Analysis of Rank Data with Covariates and Heterogeneous Rankers...................................................... Xinran Li, Dingdong Yi and Jun S. Liu 1 The …
M Oesting, K Strokorb, P Barbillon, A Fadikar, RB Gramacy, R Herbei, ...
Statistical Science [ISSN 0883-4237 (print); ISSN 2168-8745 (online)] 37 (1), 2022
2022
DECONSTRUCTIVE ANALYSIS OF DIGITAL PATHOLOGY INFERENCES
US Patent App. No. 63/394,934, 0
The system can't perform the operation now. Try again later.
Articles 1–13